Industry News
Diindolylmethane Suppresses Ovarian Cancer
Jan 26, 2012
Ovarian cancer is a major cause of death worldwide. Approximately 25,000 women will be diagnosed with ovarian cancer this year and 15,000 women will die from it in the United States alone. The novel anti-cancer drug diindolylmethane (DIM) has been shown in laboratory to inhibit the growth of ovarian cancer cells... Read More
Blood-Forming Stem Cells' Growth Identified
Jan 26, 2012
Scientists with the new Children's Research Institute at UT Southwestern Medical Center have identified the environment in which blood-forming stem cells survive and thrive within the body, an important step toward increasing the safety and effectiveness of bone-marrow transplantation. Institute investigators led by Dr... Read More
Cocoa Could Prevent Intestinal Pathologies Such As Colon Cancer
Jan 26, 2012
A new study on living animals has shown for the first time that eating cocoa (the raw material in chocolate) can help to prevent intestinal complaints linked to oxidative stress, including colon carcinogenesis onset caused by chemical substances... Read More
Indications Of A Benefit In Primary HPV Testing
Jan 26, 2012
Precursors of cervical cancer can be detected and treated earlier / Risk of over-treatment Studies currently available provide indications and a "hint" that precursors of cervical cancer can be detected and treated earlier, and consequently tumours occur less often, in women who underwent testing for human papillomavirus (HPV)... Read More
Solving The Mystery Of Membrane Fusion
Jan 26, 2012
The many factors that contribute to how cells communicate and function at the most basic level are still not fully understood, but researchers at Baylor College of Medicine have uncovered a mechanism that helps explain how intracellular membranes fuse, and in the process, created a new physiological membrane fusion model. The findings appear in the current edition of the journal PLoS Biology... Read More
A 'Disruptive Science' Ready For Commercial Development - Gene Therapy
Jan 26, 2012
The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology, which has demonstrated both its effectiveness and feasibility, says James Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy in a provocative commentary and accompanying videocast... Read More
Indications Of A Benefit In Primary HPV Testing
Jan 26, 2012
Precursors of cervical cancer can be detected and treated earlier / Risk of over-treatment Studies currently available provide indications and a "hint" that precursors of cervical cancer can be detected and treated earlier, and consequently tumours occur less often, in women who underwent testing for human papillomavirus (HPV)... Read More
Oxaliplatin Improves Colon Cancer Survival Rates
Jan 25, 2012
An investigation published Jan. 20 in The Journal of the National Cancer Institute reveals that individuals in the general population with stage III colon cancer showed improved survival rates when they were administered with 5-fluorouracil (5FU), a commonly used cancer treatment, in combination with oxaliplatin. Colon cancer is one of the leading causes for illness and death worldwide... Read More
Potential New Pathway Can Overcome Glioblastoma Resistance
Jan 25, 2012
Glioblastoma is the most prevalent and most aggressive malignant brain tumor in humans, and is one of the most resistant to current treatments. Individuals with the disease typically survive around 15 months. Earlier research concentrated on activating the (apoptosis) cell death pathway through therapeutic agents like tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)... Read More
Dutasteride Slows Down Early Stage Prostate Cancer Progression
Jan 25, 2012
A study published Online First in The Lancet has found that a common medication (dutasteride) used to treat enlargement of the prostate, may also reduce the need for treatments that pose risks of incontinence and impotence and delay growth of early-stage prostate cancer... Read More
Previous Page Next Page